Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Argus Health
Daiichi Sankyo
Federal Trade Commission

Generated: August 17, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Nitrofurantoin, and what generic Nitrofurantoin alternatives are available?

Nitrofurantoin is a drug marketed by Elkins Sinn, Sun Pharm Inds, Mylan, Watson Labs, Sandoz, Impax Labs Inc, Nostrum Labs Inc, Ivax Sub Teva Pharms, Amneal Pharms, Actavis Mid Atlantic, Whiteworth Town Plsn, Novel Labs Inc, Actavis Labs Fl Inc, Watson Labs Inc, and Ranbaxy Labs Ltd. and is included in twenty-seven NDAs.

The generic ingredient in NITROFURANTOIN is nitrofurantoin; nitrofurantoin, macrocrystalline. There are nineteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.

Summary for Tradename: NITROFURANTOIN

Suppliers / Packagers: see list23
Bulk Api Vendors: see list47
Clinical Trials: see list21
Patent Applications: see list3,993
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NITROFURANTOIN at DailyMed

Pharmacology for Tradename: NITROFURANTOIN

Drug ClassNitrofuran Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
nitrofurantoin, macrocrystalline
CAPSULE;ORAL070249-001Jun 24, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
nitrofurantoin, macrocrystalline
CAPSULE;ORAL073696-003Dec 31, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
nitrofurantoin, macrocrystalline
CAPSULE;ORAL091095-002Jun 18, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
TABLET;ORAL085796-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
nitrofurantoin, macrocrystalline
CAPSULE;ORAL091095-003Jun 18, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Johnson and Johnson
Express Scripts
Farmers Insurance
US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus